Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 14Nasopharyngeal Carcinoma 8Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Pancreatic Neoplasms 2Locally Advanced Malignant Neoplasm 2Adenocarcinoma 2Thymoma 1Small Cell Lung Cancer Limited Stage 1Rectal Diseases 1Quality of Life 1Patients With Esophageal Cancer(â…¡-â…¢) 1Pathologic Complete Response 1Neoplasms, Glandular and Epithelial 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Neoplasm Metastasis 1Neoadjuvant Chemotherapy 1Nasopharyngeal Neoplasms 1Lymphoma 1Lymphatic Metastasis 1Locally Advanced Rectal Cancer 1Locally Advanced Gastric Cancer 1

Interventions

olaparib 1niraparib 1anlotinib 1Sorafenib 1Radiofrequency Ablation 1Ocoxin 1Chemoradiotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasms, Glandular and Epithelial × Chemoradiotherapy × Clear all
NCT01037049 2018-09-17

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Royal Marsden NHS Foundation Trust

Phase 2 Unknown
237 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Adenocarcinoma, Mucinous, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡